RIDASCREEN® Anti-IFX Antibodies
Intended use:RIDASCREEN® Anti-IFX Antibodies is an enzyme linked immunoassay intended for the quantitative determination of antibodies to infliximab (ATI) in human serum and plasma. Key features [...]
Vedolizumab: New option for IBD patients
If conventional IBD treatments aren’t working, vedolizumab is an alternative. Therapeutic drug monitoring helps improve treatment success with vedolizumab.